• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/46

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

46 Cards in this Set

  • Front
  • Back
Hodgkin's
age
younger than NHL
Hodgkin's
incidence
increased slightly
male and female same
hodgkin's
orgin
unifocal
hodgkin's
pattern of spread
predictable
hodgkin's
rold of surgery
diagnosis
hodgkin's
role of RT
Primary tx for early-stage or combined with chemo for advanced
hodgkin's
chemo agents
MOPP
ABVD
ChIVPP
hodgkin's
survival
85% overall 5 year
81% overall 10 year
non-hodgkin's
incidence
highest in US
higher in males
non-hodgkin's
age
over 50
non-hodgkin's
origin
focal
non-hodgkin's
pattern of spread
unpredictable
non-hodgkin's
role of surgery
diagnosis
non-hodgkin's
role of RT
Role of RT has decreased as chemo regimens have become more effective.
non-hodgkin's
cheo agents
single alkalating agents
CVP
CHOP
non-hodgkin's
survival
65% overall 5 year
54% overall 10 year
non-hodgkin's
2 RT portals

areas blocked
1. Involved-field irradiation
2. Extended-field irradiation

Block: lungs, spinal cord, larynx, heart, humoral and femoral heads, kidneys, gonads, and iliac crest bone marrow.
hodgkin's
2 RT portals

areas blocked
1. Total nodal irradiation: (Inverted Y)
2. Subtotal nodal irradiation

Block: lungs, spinal cord, larynx, heart, humoral and femoral heads, kidneys, gonads, and iliac crest bone marrow.
hodgkin's
chemo role
Treats all sites of disease at the outset and reduces bulky disease to facilitate subsequent irradiation
non-hodgkin's
chemo role
Mainstay of tx as NHLs present as systemic disease
hodgkin's
RT dose
36-44Gy in 1.5-1.8Gy fractions
non-hodgkin's
RT dose
30-40Gy in 1.5-2.0Gy fractions
Stage I
single node region or lymphoid structure
Stage IE
single extralymphatic organ/site
Stage II
2 or more node regions
same side of diaphragm
Stage IIE
single node region + localized single extralymphatic orgin/site
Stage III
node regions
both sides of diaphragm
Stage IIIE
+/- involvement of localized, single extralymphatic organ/site
Stage IIIS
+/- involvement of spleen
Stage IIIE+S
+/- involvement of both
Stage IV
diffuse involvement of extralymphatic organ/site +/- node regions
multiple myeloma
neoplastic profliferation cells
malignant plasma cell turmor
multiple myeloma
race of highest incidence
non-white
multiple myeloma
symptoms
bone pain
multiple myeloma
3 roles of RT
1. Palliation or pain relief
2. Prevention of pathologic fractures in weight-bearing bones
3. Spinal cord compression
multiple myeloma
role of chemo
palliation of pain
multiple myeloma
chemo agents
Alkylating agents (Melphalan) combined with prednisone
VAD
VBCMP
5 acute
nausea
vomiting
fatigue
erythema
change in bowels
5 chronic
sterility
BM suppression
Pneumonitis
Pericarditis
Hypothyroidism
mantle nodes
Mediastinal, hilar, cervical, axillary, and supraclavicular and infraclavicular nodes.
mini mantle
Cervical, axillary, and supraclavicular and infraclavicular nodes.
extended mantle
Mantle including para-aortic nodes to L3 or L4 and splenic pedicle.
spade
Para-aortic, splenic pedicle (or spleen), and common iliac nodes.
Inverted Y
Spleen or splenic pedicle, para-aortic, iliac, and inguinal and femoral nodes.
Total nodal irradiation (TNI)
mantle, para-aortic/splenic pedicle (or spleen), and pelvis or mantle and inverted Y.
Subtotal nodal irradiation (STNI)
Mantle and para-aortic/splenic pedicle (or spleen).